$GILD Company News

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 12:49 PM

$GILD Company News

Gilead Sciences shares slide 1.7%
9:35 a.m. Nov. 19, 2014
- Sue Chang

Are consumers getting gouged on health care?
12:58 p.m. Nov. 18, 2014
- Russ Britt

The double-edged sword of growth-stock speculation
2:29 p.m. Nov. 14, 2014
- The Trading Deck

10 S&P 500 companies with the fastest revenue growth
8:28 a.m. Nov. 11, 2014
- Philip van Doorn

Merck, Dendreon miss out on health-care rally
12:39 p.m. Nov. 10, 2014
- Russ Britt

Gilead Sciences rises 2% to top S&P 500 gainers
9:31 a.m. Nov. 10, 2014
- Sue Chang

Visa shares rise after hours on earnings beat
6:50 p.m. Oct. 29, 2014
- Sue Chang

Warren Buffett best wear his trunks as Fed preps to end (pause) the printing
8:34 a.m. Oct. 29, 2014
- Shawn Langlois

Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang

Updates, advisories and surprises
5:01 p.m. Oct. 28, 2014
- MarketWatch

Sales of Gilead's pricey hepatitis C drug slow
4:26 p.m. Oct. 28, 2014
- MarketWatch.com

Gilead Sciences' stock pulls back from record high close after earnings miss
4:14 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead's stock drops 3.6% in after-hours trade after Q3 results
4:09 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln
4:08 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales top FactSet consensus estimate of $5.99 bln
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago
4:07 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Q3 net EPS $1.67 vs. 47 cents a year ago
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore

Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92
4:06 p.m. Oct. 28, 2014
- Tomi Kilgore

Two biotech leaders to watch
2:12 p.m. Oct. 28, 2014
- The Trading Deck

France gets larger discount on Sovaldi than its neighbors

45 min ago12:04 p.m. Nov. 20, 2014
- Seeking Alpha

Global drug tab will breach trillion dollar mark this year

7:41 a.m. Today7:41 a.m. Nov. 20, 2014
- Seeking Alpha

CNBC's Stock Pops & Drops From November 19

6:38 a.m. Today6:38 a.m. Nov. 20, 2014
- benzinga.com

Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog

5:57 p.m. Nov. 19, 2014
- Zacks.com

Why We're Huge Fans Of Gilead

4:33 p.m. Nov. 19, 2014
- Seeking Alpha

Gilead buys FDA voucher for $125M

3:59 p.m. Nov. 19, 2014
- Seeking Alpha

Gilead: Pipeline Now Includes Potential Renal Blockbuster

11:35 a.m. Nov. 19, 2014
- Seeking Alpha

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

11:23 a.m. Nov. 19, 2014
- Zacks.com

Update: Gilead's Harvoni Receives Marketing Authorization In Europe

11:17 a.m. Nov. 19, 2014
- Seeking Alpha

Stock Market News for November 19, 2014 - Market News

10:10 a.m. Nov. 19, 2014
- Zacks.com

Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High

4:09 p.m. Nov. 18, 2014
- TheStreet.com

Gilead's Value Without Its Hep C Franchise

4:07 p.m. Nov. 18, 2014
- Seeking Alpha

Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide

2:23 p.m. Nov. 18, 2014
- TheStreet.com

Stock Movers: Why 4 Big Drug Stocks Are Rising Today

1:38 p.m. Nov. 18, 2014
- Investors Business Daily

Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni

10:48 a.m. Nov. 18, 2014
- TheStreet.com

Buy Gilead Sciences Now At A Historic Low Valuation

8:52 a.m. Nov. 18, 2014
- Seeking Alpha

Dispelling Some Of The Myths Surrounding Gilead Sciences.

8:22 a.m. Nov. 18, 2014
- Seeking Alpha

Trade of the Day: Gilead Sciences (GILD)

3:16 a.m. Nov. 18, 2014
- InvestorPlace.com

Trade of the Day: Gilead Sciences Stock on Sale

7:56 p.m. Nov. 17, 2014
- InvestorPlace.com

Incyte Building Blockbuster Drug One Disease At A Time

2:58 p.m. Nov. 17, 2014
- Investors Business Daily

Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power
8:45 a.m. Today8:45 a.m. Nov. 20, 2014
- PR Newswire - PRF

Knight Sells Priority Review Voucher to Gilead
5:11 p.m. Nov. 19, 2014
- Marketwired

European Commission Grants Marketing Authorization for Gilead’s
Harvoni®▼ (Ledipasvir/Sofosbuvir), the First
Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C
Patients With Genotype 1 and 4
10:07 a.m. Nov. 18, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba
8:45 a.m. Nov. 18, 2014
- PR Newswire - PRF

Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene
9:10 a.m. Nov. 14, 2014
- PR Newswire - PRF

Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com
8:45 a.m. Nov. 14, 2014
- PR Newswire - PRF

Gilead Prices $4 Billion of Senior Unsecured Notes
5:59 p.m. Nov. 12, 2014
- BusinessWire - BZX

Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper
8:45 a.m. Nov. 12, 2014
- PR Newswire - PRF

Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of
Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Gilead Announces Harvoni Study Results in Chronic Hepatitis C
Patients with Advanced Liver Disease and Those Who Failed Prior Treatment
8:02 a.m. Nov. 11, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power
8:45 a.m. Nov. 10, 2014
- PR Newswire - PRF

Medifocus to Be Broadcast on BNN and Fox Business News on November
8th and 9th, 2014
10:56 a.m. Nov. 7, 2014
- Marketwired

Linkage Biosciences Adds to Board Leadership
8:02 a.m. Nov. 7, 2014
- Marketwired

Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver
9:31 a.m. Nov. 6, 2014
- PR Newswire - PRF

Gilead Submits New Drug Application to U.S. Food and Drug
Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet
Regimen for HIV
8:32 a.m. Nov. 6, 2014
- BusinessWire - BZX

Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties
8:45 a.m. Nov. 4, 2014
- PR Newswire - PRF

Life-Science New Build Report: 200 New North American Sites in
Planning Represent Potential $15 Billion Investment, an Industrial
Info News Alert
6:16 a.m. Nov. 4, 2014
- Marketwired

Gilead Sciences Once Again Tops the List of California's Most Honored
Companies in Institutional Investor's All-America Executive Team
Ranking
6:15 a.m. Nov. 4, 2014
- Marketwired

Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro
8:45 a.m. Oct. 30, 2014
- PR Newswire - PRF

Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
8:35 a.m. Oct. 29, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ImmVira's Bladder Cancer Trials: Promising Data Revealed

Tackling Bladder Cancer with Innovation In a world where every budding biotech claims they're on the cusp of revolutionizing cancer treatment, ImmVira's recent data on their oncolytic immunotherapy, MVR-T3011, stands out like a bright flash in a murky market. Presented at the prestigious European Society for Medical Oncology (ESMO) Congress 2026 in Suzhou, these updates...

Resilience: From Trauma to Shielding Powerhouses

A Childhood Steeped in Shadows If you think it's all Wall Street pulse for me, think again. Sometimes you stumble upon stories that hit the gut with more force than any market crash. Enter David Seymour's tale, wrapped up in his newly released autobiography from Palmetto Publishing, bearing the intriguingly gritty title: From paperboy to Secret Service Special Agent. This...

ThreatLocker Launches Global AI Awareness Campaign

Kicking Off with Pop Culture Pizzazz Ah, the sweet sound of a campaign that knows how to tug at the heartstrings of nostalgia. ThreatLocker has gotten creative with its latest strategy to get people buzzing about AI safety. They're unleashing a worldwide campaign themed around 'Terminator 2.' Now that's a throwback! If you've ever caught yourself wide-eyed at the edge of...

Camel Group Expands Battery Portfolio at Canton Fair

A Grand Display at the Canton Fair Well, here's one you don't see every day: Camel Group putting on quite the show at the 140th China Import and Export Fair, better known to us as the Canton Fair. Kicked off on October 15, 2026, in Guangzhou, this grand event paraded 'Advanced Manufacturing' as its theme, and Camel's booth was packed to the brim with what might just be...

ZPMC's Wind Power and Port Projects Earn Top Honors

Wind Farms and Ports: A Winning Formula National applause rings out for Shanghai Zhenhua Heavy Industries Co., Ltd. (ZPMC) as they snagged top honors in the recent National Quality Engineering Awards. It's about time folks recognized the heavy lifting these projects do in reshaping our energy and port infrastructure. Two of their standout projects walked away with...

Encompass Health Expands With Texas Rehab Hospital

A New Chapter in San Antonio's Healthcare Landscape Breaking ground in Texas, Encompass Health has unveiled its latest addition: a 50-bed hospital in San Antonio's Westover Hills. With sheer determination, the largest owner of inpatient rehabilitation hospitals in the U.S. has made its mark, and this isn't just any facility—at over 54,000 square feet, it's a hub for...

Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

Duni Group Faces Ups and Downs in Q3 2026

Navigating Choppy Waters: Duni's Third Quarter 2026 Alright, folks, let's dive into the latest from Duni Group—a company feeling the pinch but pushing through with some resilience. The third quarter 2026 report has just landed, and while some numbers are headed up, plenty are a bit of a gut punch. This isn't a crisis, but it's no smooth sailing either. Let's cut through...

Groundbreaking Sale: Lani Automotive Acquires Iowa Dealership

A shift in the automotive retail world takes place with Lani Automotive Group's latest move. They've just picked up their first franchised dealership, Mount Pleasant Chevrolet GMC Chrysler Dodge Jeep Ram in Iowa. It's a mouthful, sure, but it packs a punch in terms of potential growth. Why This Sale Stands Out The deal was brokered by Performance Brokerage Services, which...

Marengo: Bold Moves in TMB-H Tumor Treatment

A New Hope for Tough Tumors? Marengo Therapeutics is stirring up the oncology world with some intriguing Phase 2 results from their STARt-001 clinical trial, revealing invikafusp alfa's potential as a single-agent therapy. This hasn’t been a walk in the park, mind you; we're talking about dealing with TMB-H solid tumors that typically thumb their noses at immune...